{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:33:37Z","timestamp":1784691217336,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jns.2016.12.070","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T16:46:17Z","timestamp":1483548377000},"page":"53-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Dopamine agonist withdrawal syndrome: A comprehensive review"],"prefix":"10.1016","volume":"374","author":[{"given":"Xin Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.12.070_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2016.12.070_bb0010","article-title":"Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson's disease center [abstract]","volume":"31","author":"Patel","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.12.070_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2016.12.070_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.parkreldis.2012.06.006","article-title":"Dopamine agonist withdrawal syndrome in a patient with restless leg syndrome","volume":"19","author":"Dorfman","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.12.070_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2011.06.043","article-title":"Neural reward processing under dopamine agonists: imaging","volume":"310","author":"Kassubek","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2016.12.070_bb0030","article-title":"Higher doses of dopamine agonists, impulse control disorders and history of deep brain stimulation (DBS): risk factors for dopamine agonists withdrawal syndrome (DAWS)? [abstract]","volume":"31","author":"Garcia","year":"2016","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.jns.2016.12.070_bb0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.parkreldis.2012.05.012","article-title":"Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease","volume":"18","author":"Cunnington","year":"2012","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16308632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16308632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T10:22:23Z","timestamp":1536142943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16308632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":7,"alternative-id":["S0022510X16308632"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.12.070","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine agonist withdrawal syndrome: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.12.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}